Effusion Lymphoma
📧 Sign up to get email alerts when something new happens for Effusion Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
This clinical trial update describes ongoing specimen collection from participants with HIV infection, KSHV infection, and virus-related pre…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease [Phase 2]
A National Cancer Institute-supported Phase 2 trial evaluating daratumumab in relapsed/refractory primary effusion lymphoma, plasmablastic l…
-
CLINICAL_TRIALS other · 2026-01-20Clinical Trial Update: Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal Analysis
An update on a retrospective longitudinal study evaluating bone mineral density in people living with HIV with KSHV-associated malignancies,…
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating lenalidomide in combination with modified DA-EPOCH and rituximab (EPOCH-R2) for primary effusion lymphom…
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas [Phase 1, Phase 2]
Clinical trial evaluating vorinostat in combination with chemotherapy and rituximab for HIV-related and other aggressive B-cell lymphomas; t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas [Phase 2]
Phase 2 trial of pegylated liposomal doxorubicin (Doxil) with rituximab for relapsed AIDS-related non-Hodgkin lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma [Phase 2]
A Phase 2 study of Bortezomib with antiviral therapy followed by effusion drainage, Bevacizumab, and combination chemotherapy for primary ef…